Immunohistochemistry showed significantly higher CD3, CD3-IL17, FoxP3, and RORγT cells in colon cancer, but not in adenomatous-tissues as assessed by immune-stained cell counts. This evidence concerns the gene FOXP3 and malignant colon neoplasm.